Drug Intelligence Database
Structured insights into global innovative drugs across oncology, rare diseases, and targeted therapy.
All
Oncology
Rare Disease
Gene Therapy
Enhertu
Daiichi Sankyo / AstraZeneca
ADC
HER2
FDA / China
HER2-targeted antibody-drug conjugate with strong efficacy in HER2-mutant NSCLC.
View Analysis →
Zongertinib
Boehringer Ingelheim
TKI
HER2 TKD
FDA
Selective HER2 TKI showing high ORR in NSCLC.
View Analysis →
Sevabertinib
Bayer
TKI
HER2/EGFR
China
Dual HER2/EGFR inhibitor for previously treated NSCLC.
View Analysis →
Zynteglo
Bluebird Bio
Gene Therapy
β-thalassemia
FDA / EMA
Lentiviral gene therapy correcting β-globin deficiency.
View Analysis →
Leniolisib
Pharming Group
PI3Kδ inhibitor
APDS
Japan
Precision immune pathway modulation therapy.
View Analysis →